Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and-9: Implications for chemotaxis

被引:34
|
作者
Denney, Helen [1 ]
Clench, Malcolm R. [1 ]
Woodroofe, M. Nicola [1 ]
机构
[1] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England
关键词
Chemokines; Processing; Chemotaxis; CCL2; CXCL10; MMP-2; MMP-9; Matrix metalloproteinase; Multiple sclerosis; Cell migration; GELATINASE-B; POSTTRANSLATIONAL MODIFICATIONS; RECEPTOR; EXPRESSION; IP-10; CXCR3; ANTAGONISTS; ENZYME; RANTES; MCP-2;
D O I
10.1016/j.bbrc.2009.02.164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteolytic processing of chemokines is a complex process that can result in dramatic effects on their chemotactic activity. Results from gel electrophoresis and mass spectrometry using recombinant CCL2 and CXCL10, incubated with either MMP-2 or -9, indicate that both chemokines are cleaved by the enzymes. N-terminal truncation of four amino acids from CCL2. and four or five residues from CXCL10 occurred, but removal of four residues from the C-terminus of CXCL10 was also observed with both MMPs. The speed of the reaction was chemokine-dependent, with N-terminal processing of CCL2 being complete within 3 h, whereas activity of the MMPs on CXCL10 remained incomplete at 48 h. The effect on the chemotactic potential of N-terminal truncation of CCL2 by MMPs-2 and -9 was investigated using in vitro migration assays. Monocytic cells exhibited a 2-fold reduction in migration to MMP-cleaved CCL2 variants, compared to intact CCL2. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 50 条
  • [21] Different roles of matrix metalloproteinases-2 and-9 after human ischaemic stroke
    Lucivero, V.
    Prontera, M.
    Mezzapesa, D. M.
    Petruzzellis, M.
    Sancilio, M.
    Tinelli, A.
    Di Noia, D.
    Ruggieri, M.
    Federico, F.
    NEUROLOGICAL SCIENCES, 2007, 28 (04) : 165 - 170
  • [22] Matrix metalloproteinases-2 and-9 in cervical cancer:: different roles in tumor progression
    Rauvala, M.
    Aglund, K.
    Puistola, U.
    Turpeenniemi-Hujanen, T.
    Horvath, G.
    Willen, R.
    Stendahl, U.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 1297 - 1302
  • [23] Multiplex Assessment of Serum Chemokines CCL2, CCL5, CXCL1, CXCL10, and CXCL13 Following Traumatic Brain Injury
    Yuwen Chen
    Ying Wang
    Jian Xu
    Tingting Hou
    Jing Zhu
    Yingzi Jiang
    Liying Sun
    Chunling Huang
    Lulu Sun
    Su Liu
    Inflammation, 2023, 46 : 244 - 255
  • [24] Expressional changes of matrix metalloproteinases-2 and-9 in abdominal aorta in patients with atherosclerosis
    Grigoryan, A.
    Dimitrova, A.
    Betova, T.
    Tisheva, S.
    Kostov, K.
    Apostolova, M.
    CARDIOVASCULAR RESEARCH, 2014, 103
  • [25] Estrogen activates matrix metalloproteinases-2 and-9 to increase beta amyloid degradation
    Merlo, Sara
    Sortino, Maria Angela
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2012, 49 (04) : 423 - 429
  • [26] Matrix metalloproteinases-2,-8, and-9 in lungs of preterm infants with respiratory distress
    Cederqvist, K
    Sorsa, T
    Tervahartiala, T
    Andersson, S
    PEDIATRIC RESEARCH, 2000, 47 (04) : 354A - 354A
  • [28] Matrix metalloproteinases-2 and-9 expression in dogs with visceral leishmaniasis: A systematic review
    Da Silva, Renata Rocha
    Fontes Vasconcelos, Fernanda de Santana
    Campos, Roseane Nunes de Santana
    Tavares, Debora dos Santos
    Santos, Priscila Lima dos
    CYTOKINE, 2023, 168
  • [29] Influence of the treatment with methylprednisolone in the expression of the chemokines CXCL10 and CCL2 in serum and cerebrospinal fluid of patients with multiple sclerosis
    Moreira, MA
    Tilbery, CP
    Teixeira, AL
    Monteiro, LP
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S272 - S272
  • [30] Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and-9 and their inhibitors
    Sawicki, G
    Marcoux, Y
    Sarkhosh, K
    Tredget, E
    Ghahary, A
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2005, 269 (1-2) : 209 - 216